SCHEMBL16291545

SCHEMBL16291545

O=C(O)c1ccnc(CNCc2ccc(-c3ccccc3)o2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 0.54
▸ MEN1 O00255 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ NPC1 O15118 1/20 0.53
▸ RXFP1 Q9HBX9 1/20 0.53
▸ KDM5B Q9UGL1 5/20 0.50
▸ KDM4A O75164 3/20 0.50
▸ KDM5C P41229 3/20 0.50
▸ KDM4B O94953 2/20 0.50
▸ POLB P06746 3/20 0.48
▸ LDHA P00338 1/20 0.48
▸ LDHB P07195 1/20 0.48
▸ CYP2A6 P11509 1/20 0.47
▸ SIRT2 Q8IXJ6 1/20 0.44
▸ KDM6B O15054 1/20 0.44
▸ KDM5A P29375 1/20 0.44
▸ KDM2B Q8NHM5 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15637011 0.79 KDM5B (0.77) MEN1KMT2AKDM5BKDM4AKDM5C
SCHEMBL15637624 0.78 MCHR1 (0.46) KDM5BKDM4AKDM5CPOLBKDM6B
SCHEMBL19676463 0.78 CRHR1 (0.39) L3MBTL1MEN1KMT2ANPC1KDM5B
SCHEMBL15636644 0.71 KDM5B (0.51) KDM5BKDM4AKDM5CKDM4BKDM6B
SCHEMBL11126718 0.71 L3MBTL1 (0.62) L3MBTL1MEN1KMT2ANPC1RXFP1
SCHEMBL17144500 0.70 KDM5B (0.61) L3MBTL1KDM5BKDM4AKDM5CKDM4B
SCHEMBL23120658 0.70 KDM5B (0.52) KDM5BKDM4AKDM5CKDM4BKDM6B
SCHEMBL15637115 0.70 KDM5B (0.52) KDM5BKDM4AKDM5CKDM4BKDM6B
Hydrochloric Acid SCHEMBL11518602 0.69 L3MBTL1 (1.00) L3MBTL1MEN1KMT2ANPC1RXFP1
SCHEMBL16925971 0.69 KDM5B (0.51) KDM5BKDM4AKDM5CKDM4BKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10221139-B2 Inhibitors of histone demethylases GILEAD SCIENCES, INC. (US) 2019-03-05 — — US disclosed
US-10221139-B2 Inhibitors of histone demethylases GILEAD SCIENCES, INC. (US) 2019-03-05 — — US disclosed
US-10189787-B2 Inhibitors of histone demethylases GILEAD SCIENCES, INC. (US) 2019-01-29 — — US disclosed
US-10189787-B2 Inhibitors of histone demethylases GILEAD SCIENCES, INC. (US) 2019-01-29 — — US disclosed
EP-3023415-B1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES INC (US) 2017-12-06 — — EP disclosed
EP-3023415-B1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES INC (US) 2017-12-06 — — EP disclosed
US-20170320827-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2017-11-09 — — US disclosed
US-20170320827-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2017-11-09 — — US disclosed
US-20170320827-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2017-11-09 — — US disclosed
EP-3150582-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. (US) 2017-04-05 — — EP disclosed
US-9611219-B2 — — 2017-04-04 — — US disclosed
EP-2903968-B1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES INC (US) 2016-12-07 — — EP disclosed
EP-3023415-A1 INHIBITORS OF HISTONE DEMETHYLASES Epitherapeutics ApS (DK) 2016-05-25 — — EP disclosed
EP-3023415-A1 INHIBITORS OF HISTONE DEMETHYLASES Epitherapeutics ApS (DK) 2016-05-25 — — EP disclosed
US-20150203453-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2015-07-23 — — US disclosed
US-20150203453-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2015-07-23 — — US disclosed
US-20150203453-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2015-07-23 — — US disclosed
US-20140371195-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2014-12-18 — — US disclosed
US-20140371195-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2014-12-18 — — US disclosed
US-20140371195-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2014-12-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10189787-B2 Inhibitors of histone demethylases EHMT1, KDM1B, EHMT2 L3MBTL1 1673/4885MEN1 4042/4885KMT2A 47/4885
US-20150203453-A1 INHIBITORS OF HISTONE DEMETHYLASES EHMT1, KDM1B, EHMT2 L3MBTL1 1633/4885MEN1 3938/4885KMT2A 51/4885
US-20140371195-A1 INHIBITORS OF HISTONE DEMETHYLASES EHMT1, KDM1B, EHMT2 L3MBTL1 1673/4885MEN1 4042/4885KMT2A 47/4885
US-20170320827-A1 INHIBITORS OF HISTONE DEMETHYLASES EHMT1, KDM1B, EHMT2 L3MBTL1 1673/4885MEN1 4042/4885KMT2A 47/4885
US-10221139-B2 Inhibitors of histone demethylases EHMT1, KDM1B, EHMT2 L3MBTL1 1673/4885MEN1 4042/4885KMT2A 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback